The weight loss medication tirzepatide (Mounjaro and Zepbound) is no longer in shortage, according to the FDA. Access to ...

The United States Food and Drug Administration says the shortage of Eli Lilly’s Zepbound and Mounjaro drugs has been resolved ...

FDA has ordered specialty pharmacies and online companies to phase out knockoff versions of Eli Lilly blockbuster drugs ...

For a long time, dieting and exercise were the only realistic options for many people who wanted to lose weight, but recent ...

FDA has ordered specialty pharmacies and online companies to phase out knockoff versions of Eli Lilly's blockbuster drugs ...

Innovation, artificial intelligence, drug costs and shortages, private equity interests, and more left their mark in ...

Recent pharmaceutical innovations have opened a new path for weight loss through drugs based on gut hormones such as GLP-1 ...

Recent pharmaceutical innovations have introduced a new avenue for weight loss: drugs based on gut hormones such as GLP-1 and ...

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 502.93% and ...

Eli Lilly's Mounjaro (tirzepatide), a dual GLP-1/GIP agonist, has been heralded as a revolutionary development in both ...

FOX 13's Chief Political Investigator dives into the appearance of the bird flu in the United States, saying that additional ...